Breast Imaging Market By Technology | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Breast Imaging Market
Breast Imaging Market: By Technology (Ionizing Technologies (Mammography, Digital, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) -Forecast (2016-2021)
Report Code : HCR 0165
Published: 29 March, 2016   No. of pages: 159

  • Report Description
  • Table of Contents
  • Customization Options
Breast imaging is a technology that is widely used to obtain a high resolution visualization of breast and related diseases. Breast cancer is the most common cancer found in women. Breast imaging techniques play a major role in early diagnosis of the disease by evaluating the advancement of the disease and deciding which treatment is suitable. This breast imaging technique enables doctors to observe the efficacy of treatment and how patients would respond to it. The current practice of screening is based on mammography, ultrasound, MRI, nuclear imaging and thermography.

Breast cancer is stated as one of the leading cause of cancer-related deaths among women. The incidence of breast cancer has considerably increased since the last decade, which in turn has increased the mortality rate among women due to cancer. Women aged above 40 years or those who are going through hormone replacement therapy are at higher risk of developing breast cancer. In addition, the expanding number of aging women worldwide has aided the rise in breast cancer cases. Such factors have led the breast cancer imaging market to surge exponentially.

This report identifies the global Breast Imaging Market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to Breast Imaging Market.

Breast Imaging Market

Geographically North America dominated global Breast Imaging Market, owing to the presence of developed healthcare infrastructure and well-organized regulatory framework; North America has remained the leader in the global breast imaging market. Asia Pacific is projected to have the fastest growth, due to increasing patient population and higher government spending on breast cancer research studies.

This report segments global Breast Imaging market on the basis of technology and regional market as follows: Breast Imaging Market, by technology: 

Ionizing Technologies: 
  • Mammography, 
  • Digital Mammography, 
  • 3D Mammography, 
  • MBI, 
  • PET-CT, 
  • CBCT, 
  • PEM 

Non-ionizing Technologies: 
  • Breast MRI, 
  • Breast Ultrasound, 
  • AWBU, 
  • Breast Thermography, 
  • Optical Imaging

This report has been further segmented into major regions, which includes detailed analysis of each region such as: 
  • North America, 
  • Europe, 
  • Asia-Pacific (APAC), 
  • Rest of the World (RoW) 

This report identifies all the major companies operating in the Breast Imaging market. Some of the major companies’ profiles in detail are as follows:
  • Hologic, Inc
  • GE Healthcare 
  • Siemens Healthcare 
  • Phillips Healthcare
  • Fujifilm Holdings Corporation 
1. Breast Imaging – Market Overview
2. Executive Summary 
3. Breast Imaging Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Breast Imaging Market– Market Forces
   4.1. Drivers
      4.1.1. Increasing Prevalence of Breast Cancer
      4.1.2. Increase in regional Government Investments and Funding for Breast Cancer Treatment and Related Research
      4.1.3. Increasing awareness about breast cancer
   4.2. Restraints
      4.2.1. High cost of installation of breast imaging system
      4.2.2. Side Effects of Radiation Exposure
      4.2.3. strict Regulatory Approval Procedures
   4.3. Opportunities
      4.3.1. Technological advancements in breast cancer detection
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Breast Imaging Market, By technology
   5.1. Introduction
   5.2. Ionizing Technologies
      5.2.1. Mammography
      5.2.2. Digital Mammography
      5.2.3. 3D Mammography
      5.2.4. Molecular Breast-Specific Gamma Imaging (MBI)
      5.2.5. Positron Emission Tomography and Computed Tomography (PET-CT)
      5.2.6. Cone-Beam Computed Tomography (CBCT)
      5.2.7. Positron Emission Mammography (PEM) 
   5.3. Non-ionizing Technologies
      5.3.1. Breast MRI
      5.3.2. Breast Ultrasound
      5.3.3. AWBU
      5.3.4. Breast Thermography
      5.3.5. Optical Imaging
6. Global Breast Imaging Market, By Geography
   6.1. Europe
      6.1.1. Germany
      6.1.2. France
      6.1.3. Italy
      6.1.4. Spain
      6.1.5. Russia
      6.1.6. U.K.
      6.1.7. Rest of Europe
   6.2. Asia Pacific
      6.2.1. China
      6.2.2. India
      6.2.3. Japan
      6.2.4. South Korea
      6.2.5. Rest of Asia-Pacific
   6.3. North America 
      6.3.1. U.S.
      6.3.2. Canada
      6.3.3. Mexico
   6.4. Rest of the World (RoW)
      6.4.1. Brazil
      6.4.2. Rest of RoW
7. Breast Imaging – Market Entropy
   7.1. Expansion
   7.2. Technological Developments
   7.3. Merger & Acquisitions, and Joint Ventures
   7.4. Supply- Contract
8. Company Profiles
   8.1. Hologic, Inc.
      8.1.1. Introduction
      8.1.2. Financials
      8.1.3. Key Insights
      8.1.4. Key Strategy
      8.1.5. Product Portfolio
      8.1.6. SWOT Analysis
   8.2. GE Healthcare
      8.2.1. Introduction
      8.2.2. Financials
      8.2.3. Key Insights
      8.2.4. Key Strategy
      8.2.5. Product Portfolio
      8.2.6. SWOT Analysis
   8.3. Siemens Healthcare
      8.3.1. Introduction
      8.3.2. Financials
      8.3.3. Key Insights
      8.3.4. Key Strategy
      8.3.5. Product Portfolio
      8.3.6. SWOT Analysis
   8.4. Phillips Healthcare
      8.4.1. Introduction
      8.4.2. Financials
      8.4.3. Key Insights
      8.4.4. Key Strategy
      8.4.5. Product Portfolio
      8.4.6. SWOT Analysis
   8.5. Fujifilm Holdings Corporation
      8.5.1. Introduction
      8.5.2. Financials
      8.5.3. Key Insights
      8.5.4. Key Strategy
      8.5.5. Product Portfolio
      8.5.6. SWOT Analysis
   8.6. Gamma Medica, Inc.
      8.6.1. Introduction
      8.6.2. Financials
      8.6.3. Key Insights
      8.6.4. Key Strategy
      8.6.5. Product Portfolio
      8.6.6. SWOT Analysis
   8.7. Toshiba Corporation
      8.7.1. Introduction
      8.7.2. Financials
      8.7.3. Key Insights
      8.7.4. Key Strategy
      8.7.5. Product Portfolio
      8.7.6. SWOT Analysis
   8.8. Sonociné, Inc.
      8.8.1. Introduction
      8.8.2. Financials
      8.8.3. Key Insights
      8.8.4. Key Strategy
      8.8.5. Product Portfolio
      8.8.6. SWOT Analysis
   8.9. Aurora Imaging Technology, Inc.
      8.9.1. Introduction
      8.9.2. Financials
      8.9.3. Key Insights
      8.9.4. Key Strategy
      8.9.5. Product Portfolio
      8.9.6. SWOT Analysis
   8.10. Dilon Technologies, Inc.
      8.10.1. Introduction
      8.10.2. Financials
      8.10.3. Key Insights
      8.10.4. Key Strategy
      8.10.5. Product Portfolio
      8.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
9. Appendix
   9.1. Abbreviations
   9.2. Sources
   9.3. Research Methodology
   9.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports